RDY
Dr. Reddy's Laboratories Ltd. ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$14.13
-0.22 ▼ -1.53%
🌙 3월 13일 8:00 PM ET (한국 3/14 09:00)
$14.12
-0.01 ▼ -0.05%
| Index | - | P/E | 18.13 | EPS (ttm) | 0.78 | Insider Own | - | Shs Outstand | 0.83B | Perf Week | -1.87% |
| Market Cap | 11.76B | Forward P/E | 23.69 | EPS next Y | -9.25% | Insider Trans | - | Shs Float | 0.83B | Perf Month | -0.56% |
| Enterprise Value | 11.68B | PEG | - | EPS next Q | 0.13 | Inst Own | 13.07% | Short Float | 1.62% | Perf Quarter | 1.95% |
| Income | 0.65B | P/S | 2.96 | EPS this Y | -17.22% | Inst Trans | -10.5% | Short Ratio | 7.79 | Perf Half Y | -4.07% |
| Sales | 3.97B | P/B | 2.92 | EPS next 5Y | -2.79% | ROA | 11.67% | Short Interest | 13.48M | Perf YTD | 0.64% |
| Book/sh | 4.84 | P/C | 14.96 | EPS past 3/5Y | 28.16% 19.33% | ROE | 17.72% | 52W High | -12.62% ($16.17) | Perf Year | 11.52% |
| Cash/sh | 0.94 | P/FCF | - | Sales past 3/5Y | 10.19% 9.35% | ROIC | 15.59% | 52W Low | 15.25% ($12.26) | Perf 3Y | 31.44% |
| Dividend Est. | $0.08 (0.6%) | EV/EBITDA | - | EPS Y/Y TTM | 1.21% | Gross Margin | 57.98% | Volatility(W/M) | 1.55% 1.72% | Perf 5Y | 15.95% |
| Dividend TTM | 0.09 | EV/Sales | 2.94 | Sales Y/Y TTM | 6.69% | Oper. Margin | 17.93% | ATR (14) | 0.26 | Perf 10Y | 48.36% |
| Dividend Ex-Date | 2025/7/25 | Quick Ratio | 1.35 | EPS Q/Q | -18.89% | Profit Margin | 16.38% | RSI (14) | 45.51 | Recom | 2.75 |
| Dividend Gr. 3/5Y | 5.27% 3.13% | Current Ratio | 1.85 | Sales Q/Q | -1.04% | SMA20 | -1.99% ($14.42) | Beta | 0.33 | Target Price | $14.46 |
| Payout | 8.9% | Debt/Eq | 0.16 | Earnings | 1000000 | SMA50 | 1.26% ($13.95) | Rel Volume | 1.81 | Prev Close | $14.35 |
| Employees | 27811 | LT Debt/Eq | 0.03 | EPS/Sales Surpr. | 2.99% 2.58% | SMA200 | -0.99% ($14.27) | Avg Volume(3M) | 1.73M | Price | $14.13 |
| IPO | 2001/4/11 | Option/Short | Yes/Yes | Trades | 12647 | Volume | 3,126,587 | Change | -1.53% |
뉴스 로딩 중...